Vorinostat With Gemcitabine, Busulfan, and Melphalan With Stem Cell Transplant (SCT) in Relapsed or Refractory Lymphoid Malignancies

NCT01421173 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

78

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

DRUG: Vorinostat
DRUG: Gemcitabine
DRUG: Busulfan
DRUG: Melphalan
PROCEDURE: Stem Cell Infusion
DRUG: Rituximab
DRUG: G-CSF
DRUG: Palifermin
DRUG: Dexamethasone acetate

Sponsor

M.D. Anderson Cancer Center